Insight Capital Research & Management’s Amgen AMGN Stock Holding History

Insight Capital Research & Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-12,438	Closed	-$1.99M	–	100
2015 Q1	$1.99M	Buy	12,438 +39	+0.3%	+$6.14K	0.5%	85
2014 Q4	$1.98M	Sell	12,399 -60	-0.5%	-$9.35K	0.51%	84
2014 Q3	$1.75M	Buy	12,459 +84	+0.7%	+$11K	0.46%	76
2014 Q2	$1.47M	Sell	12,375 -37	-0.3%	-$4.28K	0.33%	87
2014 Q1	$1.53M	Sell	12,412 -12,013	-49%	-$1.46M	0.35%	87
2013 Q4	$2.79M	Sell	24,425 -35	-0.1%	-$3.98K	0.62%	63
2013 Q3	$2.84M	Buy	24,460 +996	+4%	+$108K	0.69%	50
2013 Q2	$2.31M	Buy	+23,464	New	+$2.43M	0.6%	60

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Insight Capital Research & Management's AMGN Position: Q2 2015 in Review

Insight Capital Research & Management sold out of Amgen (AMGN) in Q2 2015, closing a stake of 12,438 shares — an estimated $1.99M sold.

Insight Capital Research & Management first reported a position in AMGN in Q2 2013 and held it in 8 quarters. The position peaked at $2.84M in Q3 2013. 1,366 funds tracked by Wall St. Rank hold AMGN as of Q2 2015.

Insight Capital Research & Management reported no remaining Amgen position as of Q2 2015 after selling out during the quarter.
Insight Capital Research & Management sold 12,438 Amgen shares in Q2 2015, an estimated $1.99M.
Insight Capital Research & Management first reported a position in Amgen in Q2 2013 and held it in 8 quarters.
Insight Capital Research & Management's Amgen position peaked at $2.84M in Q3 2013.
1,366 funds tracked by Wall St. Rank held Amgen as of Q2 2015.

Based on Insight Capital Research & Management's 13F filing for Q2 2015, filed 13 Aug 2015.